- Atmofizer Technologies Inc. (ATMO) has completed its reverse takeover transaction (RTO) with Vaxxinator Enterprises Inc.
- The RTO was affected by way of a “three-cornered” amalgamation involving the company, Vaxxinator and a subsidiary of Atmofizer under the Business Corporations Act
- Atmofizer consolidated its then Class B shares and changed its name from Consolidated HCI Holdings Corporation to Atmofizer Technologies Inc.
- Former holders of Vaxxinator shares now hold approximately 97.74 per cent of the issued and outstanding shares
- Pre-RTO shareholders of Atmofizer now hold 1.13 per cent of the shares on a non-diluted basis, based on an aggregate of 73,880,271 common shares currently issued and outstanding
- Atofizer Technologies Inc. (ATMO) will begin trading its shares on the CSE once conditions for listing are satisfied and the CSE issues its final exchange bulletin confirming the completion of the RTO
Atmofizer Technologies Inc. (ATMO) has completed its reverse takeover transaction (RTO) with Vaxxinator Enterprises Inc.
The RTO was affected by way of a “three-cornered” amalgamation involving the company, Vaxxinator and a subsidiary of Atmofizer under the Business Corporations Act.
Atmofizer consolidated its then Class B shares and changed its name from Consolidated HCI Holdings Corporation to Atmofizer Technologies Inc.
It continued from a corporation existing under the Canada Business Corporations Act to a company existing under the BCBCA. Atmofizer re-designated its then class B shares to common shares.
All outstanding warrants and options to purchase Vaxxinator shares were exchanged on an equivalent basis for warrants and options to purchase common shares.
Atmofizer paid a finder’s fee to an arm’s length party. The finder’s fee was satisfied by issuing 833,333 post-consolidation common shares.
Former holders of Vaxxinator shares now hold approximately 97.74 per cent of the issued and outstanding shares.
Pre-RTO shareholders of Atmofizer now hold 1.13 per cent of the shares on a non-diluted basis, based on an aggregate of 73,880,271 common shares currently issued and outstanding.
Due to certain contractual lock-up agreements between former shareholders and Vaxxinator, an aggregate of 39,791,603 common shares issued to the shareholders are locked up from trading.
They will be gradually released from lockup over a period of 18 months from the listing on the CSE.
Atofizer Technologies Inc. (ATMO) will begin trading its shares on the CSE once conditions for listing are satisfied and the CSE issues its final exchange bulletin confirming the completion of the RTO.
